Methotrexate and radiographic disease progression in patients with rheumatoid arthritis
Kremer, J.M.
Journal of Rheumatology 26(2): 241-243
1999
ISSN/ISBN: 0315-162X PMID: 9972951 Document Number: 505168
Document emailed within 1 workday
Related Documents
Shinozawa, T.; Kameda, H.; Hama, N.; Yoshida, T.; Ohosone, Y.; Ichikawa, Y. 1998: The efficacy of combination therapy with prednisolone (PSL) and methotrexate (MTX) on radiographic progression in patients with rheumatoid arthritis (RA) Ryumachi 38(1): 14-22Kuper, I.H.; van Leeuwen, M.A.; van Riel, P.L.; Sluiter, W.J.; Houtman, N.M.; Cats, H.A.; van Rijswijk, M.H. 1999: Influence of a ceiling effect on the assessment of radiographic progression in rheumatoid arthritis during the first 6 years of disease Journal of Rheumatology 26(2): 268-276
Sokka, T.; Kautiainen, H.; Häkkinen, A.; Hannonen, P. 2004: Radiographic progression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years Journal of Rheumatology 31(6): 1073-1082
Boiardi, L.; Macchioni, P.; Meliconi, R.; Pulsatelli, L.; Facchini, A.; Salvarani, C. 1999: Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate Clinical and Experimental Rheumatology 17(4): 419-425
Wendt, T.; Eidner, T.; Bräunig, E.; Hein, G. 1999: Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis European Journal of Medical Research 4(10): 442-448
van Riel, P.L.; van der Heijde, D.M.; Nuver-Zwart, I.H.; van de Putte, L.B. 1995: Radiographic progression in rheumatoid arthritis: results of 3 comparative trials Journal of Rheumatology 22(9): 1797-1799
Phillips, C.A.; Cera, P.J.; Mangan, T.F.; Newman, E.D. 1992: Clinical liver disease in patients with rheumatoid arthritis taking methotrexate Journal of Rheumatology 19(2): 229-233
Levitsky, A.; Wick, M.C.; Möttönen, T.; Leirisalo-Repo, M.; Laasonen, L.; Korpela, M.; van Vollenhoven, R.F.; Rantalaiho, V. 2016: Early treatment intensification induces favourable radiographic outcomes according to predicted versus observed radiographic progression in early rheumatoid arthritis: a subanalysis of the randomised FIN-RACo and NEO-RACo trials Clinical and Experimental Rheumatology 34(6): 1065-1071
Sokka, T.M.; Kaarela, K.; Möttönen, T.T.; Hannonen, P.J. 1999: Conventional monotherapy compared to a "sawtooth" treatment strategy in the radiographic progression of rheumatoid arthritis over the first eight years Clinical and Experimental Rheumatology 17(5): 527-532
Golden, M.R.; Katz, R.S.; Balk, R.A.; Golden, H.E. 1995: The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis Journal of Rheumatology 22(6): 1043-1047
Krause, D.; Gabriel, B.; Herborn, G.; Braun, J.; Rau, R. 2014: The positive influence of methotrexate on the mortality of patients with rheumatoid arthritis is partly independent of its effect on disease activity: results of a re-evaluation 18 years after baseline Clinical and Experimental Rheumatology 32(3): 395-400
Jardine, D.L.; Colls, B.M. 2002: Hodgkin's disease following methotrexate therapy for rheumatoid arthritis New Zealand Medical Journal 115(1156): 293-294
Halla, J.T.; Hardin, J.G. 1994: Underrecognized postdosing reactions to methotrexate in patients with rheumatoid arthritis Journal of Rheumatology 21(7): 1224-1226
Tebib, J.G.; Boughaba, H.; Letroublon, M.C.; Bienvenu, J.; Noel, E.; Armanet, P.; Colson, F.; Roullet, A.; Bouvier, M. 1991: Serum IL-2 level in rheumatoid arthritis: correlation with joint destruction and disease progression European Cytokine Network 2(4): 239-243
Lafforgue, P.; Monjanel-Mouterde, S.; Durand, A.; Catalin, J.; Acquaviva, P.C. 1993: Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? a pharmacokinetic study in 33 patients Journal of Rheumatology 20(2): 263-267
Kawai, S.; Ochi, T.; Kondo, H.; Nishioka, K.; Nobuyuki, N.; Yoshino, S. 2002: A survey of the doses of methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis Ryumachi 42(1): 76-79
Idolazzi, L.; Adami, S.; Capozza, R.; Bianchi, G.; Cozzolongo, A.; Epis, O.; Fusaro, E.; Lapadula, G.; Migliore, A.; Pellerito, R.; Pucino, A.; Sinigaglia, L.; Visalli, E.; Rossini, M. 2015: Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARi study Clinical and Experimental Rheumatology 33(6): 895-899
Lioté, F.; Pertuiset, E.; Cochand-Priollet, B.; D'Agay, M.F.; Dombret, H.; Numéric, P.; D'Anglejan, G.; Kuntz, D. 1995: Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection Journal of Rheumatology 22(6): 1174-1178
El Miedany, Y.M.; Abubakr, I.H.; El Baddini, M. 1998: Effect of low dose methotrexate on markers of bone metabolism in patients with rheumatoid arthritis Journal of Rheumatology 25(11): 2083-2087
Manorot, M.; Rojanasathien, N.; Louthrenoo, W.; Tonsuwannont, W.; Teekachunhatean, S. 1998: Comparative studies of quality and bioavailability of methotrexate in Thai patients with rheumatoid arthritis Journal of the Medical Association of Thailand 81(12): 978-985